Authors: HINDMARCH I LEHFELD H DEJONGH P ERZIGKEIT H

Citation: I. Hindmarch et al., THE BAYER ACTIVITIES OF DAILY LIVING SCALE (B-ABL), Dementia and geriatric cognitive disorders, 9, 1998, pp. 20-26

Authors: LEHFELD H REISBERG B FINKEL S KANOWSKI S WIED V PITTAS J TSOLAKI M ROBERT PH HULLA F HEININGER K ERZIGKEIT H

Citation: H. Lehfeld et al., INFORMANT-RATED ACTIVITIES-OF-DAILY-LIVING (ADL) ASSESSMENTS - RESULTS OF A STUDY OF 141 ITEMS IN THE USA, GERMANY, RUSSIA, AND GREECE FROMTHE INTERNATIONAL ADL SCALE DEVELOPMENT PROJECT, Alzheimer disease and associated disorders, 11, 1997, pp. 39-44

Authors: FERRIS SH LUCCA U MOHS R DUBOIS B WESNES K ERZIGKEIT H GELDMACHER D BODICK N

Citation: Sh. Ferris et al., OBJECTIVE PSYCHOMETRIC TESTS IN CLINICAL-TRIALS OF DEMENTIA DRUGS - POSITION PAPER FROM THE INTERNATIONAL WORKING GROUP ON HARMONIZATION OFDEMENTIA DRUG GUIDELINES, Alzheimer disease and associated disorders, 11, 1997, pp. 34-38

Authors: WHITEHOUSE PJ ORGOGOZO JM BECKER RE GAUTHIER S PONTECORVO M ERZIGKEIT H ROGERS S MOHS RC BODICK N BRUNO G DALBIANCO P

Citation: Pj. Whitehouse et al., QUALITY-OF-LIFE ASSESSMENT IN DEMENTIA DRUG DEVELOPMENT - POSITION PAPER FROM THE INTERNATIONAL WORKING GROUP ON HARMONIZATION OF DEMENTIA DRUG GUIDELINES, Alzheimer disease and associated disorders, 11, 1997, pp. 56-60

Authors: WEYER G ERZIGKEIT H HADLER D KUBICKI S

Citation: G. Weyer et al., EFFICACY AND SAFETY OF IDEBENONE IN THE LONG-TERM TREATMENT OF ALZHEIMERS-DISEASE - A DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTER STUDY, Human psychopharmacology, 11(1), 1996, pp. 53-65